Faecal Microbial Transplantation by Dr Craig Haifer


Share on linkedin

Dr Craig Haifer has always been fascinated by human health.  Shortly after beginning his medical degree, he found immense fascination in the field of gastroenterology.  What followed was a particular interest in the role of the gut microbiome in the development of gastrointestinal and systemic diseases.

Dr Haifer is now a Staff Specialist in the Gastroenterology Department and Inflammatory Bowel Disease service at St Vincent’s Hospital in Sydney and a Conjoint Senior Lecturer at the School of Clinical Medicine, University of New South Wales.  As an early career researcher, he has recently received the Sister Mary Bernice, Packer Family Foundation Research Grant ($120,000) awarded by St Vincent’s Clinic Foundation (SVCF). 

Cancer Immunotherapy help’s the patient’s immune system to fight cancer and has revolutionised therapy.  However, it can come with unwanted side effects, including bowel inflammation. 

Dr Haifer’s study aims to determine the safety and effectiveness of using orally administered Faecal Microbial Transplantation (FMT) to treat bowel inflammation in patients undergoing immunotherapy.

To help fund research taking place on the St Vincent’s Darlinghurst Health Innovation Precinct, please click here to donate now.


Getting the moral and financial support from SVCF allows us to establish research which is recognised worldwide and has the potential to improve patient outcomes.”